Asthma is a chronic inflammatory disease of the airways characterized by airway hyperresponsiveness and reversible airflow obstruction. It is caused by a combination of genetic and environmental factors such as family history, prenatal sensitization, exposure to allergens and pollutants, and infections. Asthma is classified based on severity from mild to severe. Symptoms include wheezing, coughing, chest tightness, and shortness of breath. Diagnosis involves assessing symptoms and lung function tests. Treatment focuses on bronchodilators and inhaled corticosteroids to prevent symptoms and exacerbations.
Pneumonia ,Management of Patients withLower Respiratory Disorders PNEUMONIA Jamilah AlQahtani
Management of Patients withLower Respiratory Disorders PNEUMONIA At the end of the lecture, the student will be able to
Describe the patho-physiology of the disease.
Discuss the major risk factors and clinical manifestations of the disease.
Use the nursing process as a framework for patient care.
Discuss medical , surgical and nursing management of the disease.
At the end of the lecture, the student will be able to
Describe the patho-physiology of the disease.
Discuss the major risk factors and clinical manifestations of the disease.
Use the nursing process as a framework for patient care.
Discuss medical , surgical and nursing management of the disease.
SARS stands for severe acute respiratory syndrome . caused by a corona virus . major outbreak in south china in 2002 with fatality of about 10% and 800 deaths in a single outbreak.
prdiatrics notes, croup, upper respiratoty track infection
to download this presentation from this link
https://mohmmed-ink.blogspot.com/2020/11/pediatrics-notes-croup.html
Asthma is a condition in which your airways narrow and swell and produce extra mucus. This can make breathing difficult and trigger coughing, wheezing and shortness of breath. For some people, asthma is a minor nuisance.
Content & references in part including multimedia content (illustrations, videos) might be taken from the public domain, by no means, aiming at copyrights infringement. All intellectual property rights reserved with the owners.
Pneumonia ,Management of Patients withLower Respiratory Disorders PNEUMONIA Jamilah AlQahtani
Management of Patients withLower Respiratory Disorders PNEUMONIA At the end of the lecture, the student will be able to
Describe the patho-physiology of the disease.
Discuss the major risk factors and clinical manifestations of the disease.
Use the nursing process as a framework for patient care.
Discuss medical , surgical and nursing management of the disease.
At the end of the lecture, the student will be able to
Describe the patho-physiology of the disease.
Discuss the major risk factors and clinical manifestations of the disease.
Use the nursing process as a framework for patient care.
Discuss medical , surgical and nursing management of the disease.
SARS stands for severe acute respiratory syndrome . caused by a corona virus . major outbreak in south china in 2002 with fatality of about 10% and 800 deaths in a single outbreak.
prdiatrics notes, croup, upper respiratoty track infection
to download this presentation from this link
https://mohmmed-ink.blogspot.com/2020/11/pediatrics-notes-croup.html
Asthma is a condition in which your airways narrow and swell and produce extra mucus. This can make breathing difficult and trigger coughing, wheezing and shortness of breath. For some people, asthma is a minor nuisance.
Content & references in part including multimedia content (illustrations, videos) might be taken from the public domain, by no means, aiming at copyrights infringement. All intellectual property rights reserved with the owners.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
2. INTRODUCTION
• There are two pathophysiological features of the disease are generally
agreed.
Airway Inflammation
increased airway reactivity
3. DEFINITION
• ASTHMA IS CONSIDERED TO BE A CHRONIC
INFLAMMATORY DISEASE OF THE AIRWAY
ASSOCIATED WITH HYPERRESPONSIVENESS TO
ENVIRONMENTAL STIMULI CAUSING REVERSIBLE
AIRFLOW, OBSTRUCTION AND RESPIRATORY
DISTRESS.
4. ETIOLOGY
✔ GENETICS
✔ EVIDENCE FOR PRENATAL SENSITATION TO AEROALLERGENS
✔ OTHER PRENATAL FACTORS
✔ BREAST FEEDING AND WHEEZING ILLNESS
✔ EXPOSURE TO HOUSE DUST, MITES AND PETS
✔ THE HYGIENE HYPOTHESIS
✔ BRONCHO PULMONARY DYSLASIA
✔ BRONCHIOLITIS
5. CLASSIFICATION
It is classified based on the degree of severity. It is classified into
MILD
MODERATE
SEVERE
MILD :
Occasional attack of wheezing or coughing with no symptoms
between attack.
MORERATE :
More frequent episodes, more persistent symptoms after an
exacerbation and often chronic cough, exercise tolerance may be
reduced.
6. CLASSIFICATION ctnd
SEVERE :
❖ Requiring frequent emergency attention and hospitalization.
❖ Wear med-alert bracelet and to carry a crisis plan
❖ For evaluating scoring system is helpful
❖ Greater than 10 indicates a high probability for hospital admission
❖ Greater than 12 or an arterial oxygen saturation less than 92 % on
room air should be admitted
7. PATHOPHYSIOLOGY
DUE TO ETIOLOGICAL FACTORS
AIRWAY INFLAMMATION
AIRWAY OEDEMAAND ACCUMULATION AND SECRETION OF
MUCUS
SPASM OF SMOOTH MUSCLES OF THE BROCHI AND THE
BROCHIOLES
BRONCHOSPASM AND OBSTRUCTION
NARROWING AND SHORTENING OF THE AIRWAY
8. PATHOPHYSIOLOGY ctnd
INCREASES AIRWAY RESISTANCE TO AIRFLOW
FATIGUE DECREASED RESPIRATORY EFFECTIVENESS AND
INCREASED OXYGEN CONSUMPTION
CHRONIC INFLAMMATION
PERMAMENT DAMAGE TO AIRWAY STRUCTURES
9. CLINICAL
MANIFESTAIONS
• ACUTE ATTACK
✔ Sudden or gradual onset of shortness of breath
✔ Chest tightness
✔ Wheezing
✔ Coughing
✔ Hyperinflation
✔ Sputum production
✔ Nasal discharges
✔ Sinus headaches
10. ✔ Unable to speak
✔ Decreased breath sound
✔ Presence of allergy
✔ Oedema of the nasal turbinates
✔ Middle ear effusions
✔ Conjunctivitis
• CHRONIC ASTHMA
✔ Chest deformities
✔ Weight loss
✔ Chronic illness
✔ Eczema
11. DIAGNOSTIC
EVALUATION
✔ DYSPNOEA
✔ WHEEZING AND COUGHING
✔ ACUTE EXPISODES OF SHORTNESS OF BREATH
✔ HISTORY COLLECTION
✔ PHYSICAL EXAMINATION
✔ PULMONARY FUNCTION TEST
✔ PEAK EXPIRATORY FLOW RATE {PEFR}
✔ BRONCHOPROVOCATION TESTINY
✔ SKIN TESTING
✔ RADIO ALLERGOSORBENT TEST [RAST]
✔ BLOOD COUNT CHEST RADIOGRAPHS
12. TREATMENT
• ACUTE ASTHMA
❑ Bronchodilators And Anti-inflammatory Agents
❑ Beta-adrenergic agonist
❑ Beta-2 agonist inhalation
❑ Inhale steroids
A severe attack may require 3 – 4 inhalation from a nebulizer.
During the first hour or three puffs or a equivalent of albuterol
from a mestored dose inhaler (MDI) and spacer every 5
minutes.
13. TREATMENT ctnd
• INTENSIVE CARE MANAGEMENT
✔ INRAVENOUS TERBUTALINE
✔ INTUBATION AND MECHANICALVENTILATION
• CHRONIC ASTHMA CARE
✔ INHALATION OF STEROIDS
Eg: BECLOMETHASONE
FLUONISOLIDE = 2 – 4 Times/ day
• SEVERE
✔ INHALED STEROIDS
✔ THEOPHYLLINE
14. MANAGEMENT
Mild/Moderate Episode
✔ Sit the child up
✔ Give 100% humidified oxygen to maintain sa o2 > 93%
✔ Give inhaled salbutamol via inhaler and spacer with face mask if
required
1 -5 yrs salbutamol 6 puffs x 3 times > 5 years salbutamol 12 puffs x 3 times
give prednisolone 1 – 2 mg/kg by mouth
Prognosis
yes some improvement no improvement
15. NURSING DIAGNOSIS
✔ Ineffective breathing pattern dyspnoea
related to bronchial constriction as
evidenced by increased respiratory rate.
✔ Ineffective airway clearance related to excessive secretion of sputum
as evidenced by increased respiratory rate
✔ Acute chest pain related to frequent cough as evidenced by facial
grimace.
✔ Imbalanced nutritional status less than body requirement related to
loss of appetite as evidenced by weight loss.
✔ Disturbed sleep pattern related to frequent cough as evidenced by
drowsiness of eye.